Dose–escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice-Reference-Cited by-同舟云学术

Dose–escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice

Published:2021-12-19 Issue: Volume: Page:1-9
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Ylisaukko-oja Tero¹²,Puttonen Minna³⁴,Jokelainen Jari¹²,Koivusalo Mirkka¹,Tamminen Klaus³,Torvinen Saku³,Voutilainen Markku⁵⁶

Affiliation:

1. MedEngine Oy, Helsinki, Finland

2. Faculty of Medicine, Center for Life Course Health Research, University of Oulu, Oulu, Finland

3. Takeda Oy, Helsinki, Finland

4. Division of Pharmaceutical Technology and Chemistry, Industrial Pharmacy, University of Helsinki, Helsinki, Finland

5. Division of Medicine, Turku University Hospital, Turku, Finland

6. Department of Medicine, University of Turku, Turku, Finland

Funder

Takeda Oy

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2021.2014950

Reference31 articles.

1. Inflammatory Bowel Disease

2. Ulcerative colitis

3. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

4. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

5. Tumor necrosis factor: Biology and therapeutic inhibitors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-04-23

2. Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms;Journal of Clinical Medicine;2024-03-06

3. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

4. Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study;Alimentary Pharmacology & Therapeutics;2023-02-27